glp 1 and glp2 Discovery, characterization, clinical development of the glucagon-like peptides Therapeutic Potential of GLP-2 Analogs
Description
Scientists were chasing an incretin hormone, and when GLP-1 was finally discovered, we found that it had a pronounced satiety effect, slowed down gastric emptying, and actually reduced postprandial insulin response
Methods 308 patients with type 2 diabetes mellitus (T2D) were recruited and divided into 4 groups
Only one of those is GLP-1
Understanding the science, evaluating your individual inflammatory profile, and coordinating care with rheumatology are essential before considering GLP-1 therapy
Manufacturer net pricing integrated into the PBM native environment
